These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 2687626

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A demonstration of the in vitro bacterial mutagenicity of procarbazine, using the microtitre fluctuation test and large concentrations of S9 fraction.
    Gatehouse DG, Paes DJ.
    Carcinogenesis; 1983; 4(3):347-52. PubMed ID: 6339100
    [Abstract] [Full Text] [Related]

  • 3. Thalidomide: lack of mutagenic activity across phyla and genetic endpoints.
    Ashby J, Tinwell H, Callander RD, Kimber I, Clay P, Galloway SM, Hill RB, Greenwood SK, Gaulden ME, Ferguson MJ, Vogel E, Nivard M, Parry JM, Williamson J.
    Mutat Res; 1997 Dec 12; 396(1-2):45-64. PubMed ID: 9434859
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Promutagen activation by rodent-liver postmitochondrial fractions in the L5178Y/TK cell mutation assay.
    Amacher DE, Turner GN.
    Mutat Res; 1980 Dec 12; 74(6):485-501. PubMed ID: 7464853
    [Abstract] [Full Text] [Related]

  • 7. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
    Yoshikawa K, Nohmi T, Miyata R, Ishidate M, Ozawa N, Isobe M, Watabe T, Kada T, Kawachi T.
    Mutat Res; 1982 Oct 12; 96(2-3):167-86. PubMed ID: 6755239
    [Abstract] [Full Text] [Related]

  • 8. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests.
    Gatehouse D, Wedd DJ.
    Carcinogenesis; 1984 Mar 12; 5(3):391-7. PubMed ID: 6368032
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
    Hakura A, Shimada H, Nakajima M, Sui H, Kitamoto S, Suzuki S, Satoh T.
    Mutagenesis; 2005 May 12; 20(3):217-28. PubMed ID: 15843387
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Metabolic activation of 3-nitroperylene in the Salmonella/S9 assay.
    Anderson JG, McCalla DR, Bryant DW, McCarry BE, Bromke AM.
    Mutagenesis; 1987 Jul 12; 2(4):279-85. PubMed ID: 3325759
    [Abstract] [Full Text] [Related]

  • 13. Activation and detoxification of dinitropyrenes by cytosol and microsomes from Aroclor-pretreated rats in the Ames and umu assays.
    Shane BS, Winston GW.
    Environ Mol Mutagen; 1997 Jul 12; 30(3):303-11. PubMed ID: 9366909
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Microbial mutation studies with tetrachlorvinphos (Gardona)).
    Brooks TM, Dean BJ, Hutson DH, Potter D.
    Mutat Res; 1982 Oct 12; 105(4):211-21. PubMed ID: 6752704
    [Abstract] [Full Text] [Related]

  • 20. Optimization of a pre-metabolization procedure using rat liver S9 and cell-extracted S9 in the Ames fluctuation test.
    Shao Y, Schiwy A, Glauch L, Henneberger L, König M, Mühlenbrink M, Xiao H, Thalmann B, Schlichting R, Hollert H, Escher BI.
    Sci Total Environ; 2020 Dec 20; 749():141468. PubMed ID: 32827816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.